Jurriaan Dekkers
Director of Finance/CFO at PROQR THERAPEUTICS N.V.
Profile
Jurriaan Dekkers founded Dr. Decorum.
Mr. Dekkers also currently works at Stichting Kinderpostzegels Nederland, as Member-Supervisory Board and ProQR Therapeutics NV, as Chief Financial Officer from 2022.
Mr. Dekkers also formerly worked at Acerta Pharma BV, as Chief Financial Officer & Director and AstraZeneca BV, as Chief Financial Officer.
Mr. Dekkers received his graduate degree from Rotterdam University, graduate degree in 2001 from Erasmus University Rotterdam, and undergraduate degree in 2004 from Erasmus University Rotterdam.
Jurriaan Dekkers active positions
| Companies | Position | Start |
|---|---|---|
| PROQR THERAPEUTICS N.V. | Director of Finance/CFO | 2022-09-30 |
| Stichting Kinderpostzegels Nederland | Director/Board Member | - |
Former positions of Jurriaan Dekkers
| Companies | Position | End |
|---|---|---|
| Dr. Decorum | Founder | - |
| AstraZeneca BV | Director of Finance/CFO | - |
Acerta Pharma BV
 Acerta Pharma BV Pharmaceuticals: GenericHealth Technology Acerta Pharma BV develops drugs for oncology and autoimmune diseases. It operates as a biotech company that combines technology platforms in drug discovery and development such as the covalent technology platform and the multiparametric phosphoflow cytometry platform. The company was founded by Allard Kaptein in 2012 and is headquartered in Oss, Netherlands. | Chief Executive Officer | - |
Training of Jurriaan Dekkers
| Erasmus University Rotterdam | Graduate Degree |
| Rotterdam University | Graduate Degree |
Experiences
Positions held
Connections
1st degree connections
1st degree companies
Male
Female
Members of the board
Executives
Linked companies
| Listed companies | 1 |
|---|---|
| PROQR THERAPEUTICS N.V. | Health Technology |
| Private companies | 4 |
|---|---|
| Stichting Kinderpostzegels Nederland | Miscellaneous |
| AstraZeneca BV | |
Acerta Pharma BV
Acerta Pharma BV Pharmaceuticals: GenericHealth Technology Acerta Pharma BV develops drugs for oncology and autoimmune diseases. It operates as a biotech company that combines technology platforms in drug discovery and development such as the covalent technology platform and the multiparametric phosphoflow cytometry platform. The company was founded by Allard Kaptein in 2012 and is headquartered in Oss, Netherlands. | Health Technology |
| Dr. Decorum |
- Stock Market
- Insiders
- Jurriaan Dekkers
